Navidea Biopharmaceuticals Inc Ret. on equity
What is the Ret. on equity of Navidea Biopharmaceuticals Inc?
The Ret. on equity of Navidea Biopharmaceuticals Inc is 80.10%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with ret. on equity similar to Navidea Biopharmaceuticals Inc
- 4imprint plc has Ret. on equity of 78.95%
- 3i Infotech has Ret. on equity of 79.31%
- Jarvis Securities plc has Ret. on equity of 79.44%
- The Clorox has Ret. on equity of 79.58%
- Opto Circuits (India) has Ret. on equity of 79.62%
- Ortho Regenerative Technologies has Ret. on equity of 79.79%
- Navidea Biopharmaceuticals Inc has Ret. on equity of 80.10%
- Mineworx Technologies has Ret. on equity of 80.19%
- Pressure BioSciences has Ret. on equity of 80.33%
- Pitney Bowes has Ret. on equity of 80.40%
- Automatic Data Processing has Ret. on equity of 80.49%
- Newport Exploration has Ret. on equity of 80.73%
- Stelrad Radiator has Ret. on equity of 80.74%